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Angiotensin II Induces Leukocyte–Endothelial Cell
Interactions In Vivo Via AT1 and AT2 Receptor–Mediated
P-Selectin Upregulation
Laura Piqueras, BPharm; Paul Kubes, PhD; Angeles Alvarez, BPharm; Enrique O’Connor, PhD;
Andrew C. Issekutz, MD; Juan V. Esplugues, MD, PhD; Maria-Jesus Sanz, PhD
Background—Angiotensin II (Ang II) plays a critical role in the development of vascular lesions in hypertension,
atherosclerosis, and several renal diseases. Because Ang II may contribute to the leukocyte recruitment associated with
these pathological states, the aim of the present study was to assess the role of Ang II in leukocyte–endothelial cell
interactions in vivo.
Methods and Results—Intravital microscopy of the rat mesenteric postcapillary venules was used. Sixty minutes of
superfusion with 1 nmol/L Ang II induced a significant increase in leukocyte rolling flux (83.8620.7 versus 16.463.1
cells/min), adhesion (11.461.0 versus 0.860.5 cells/100 mm), and emigration (4.060.7 versus 0.260.2 cells/field)
without any vasoconstrictor activity. These effects were not mediated by mast cell activation. Intravenous pretreatment
with AT1 (losartan) or AT2 (PD123,319) receptor antagonists significantly reduced Ang II–induced responses. A
combination of both receptor antagonists inhibited the leukocyte rolling flux, adhesion, and extravasation elicited by
Ang II at 60 minutes. Pretreatment of animals with fucoidin or an adhesion-blocking anti–rat P-selectin monoclonal
antibody abolished Ang II–induced leukocyte responses. Furthermore, rat platelet P-selectin expression was not affected
by Ang II stimulation.
Conclusions—Ang II induces significant leukocyte rolling, adhesion, and emigration, which may contribute not only to
hypertension but also to the onset and progression of the vascular damage associated with disease states in which plasma
levels of this peptide are elevated. (Circulation. 2000;102:2118-2123.)
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Angiotensin II (Ang II), the main effector peptide of therenin-angiotensin system, may contribute to the devel-
opment of vascular lesions in hypertension, atherosclerosis,
and many glomerular diseases of the kidney.1–3 In addition to
its role as a potent vasoconstrictor and regulator of blood
pressure and fluid homeostasis, Ang II seems to be involved
in the activation of monocytes and polymorphonuclear leu-
kocytes (PMNs). Ang II receptors have also been demon-
strated on monocytes.4 This may be directly relevant, because
hypertension is associated with migration of monocytes
through the vessel wall, a critical event leading to the
development of the atherosclerotic lesion that can be attenu-
ated by ACE inhibition.5,6 Furthermore, Ang II can promote
monocyte adhesion and activation in vitro7–9 and stimulates
the expression of monocyte chemoattractant protein-1
(MCP-1) and RANTES in several animal models in
vivo.5,10,11 In addition, Ang II releases a neutrophil chemoat-
tractant factor from cultures of arterial endothelial cells.12
Leukocytes migrate from the blood to sites of extravascular
injury in response to locally produced stimuli that activate
specific cell surface receptors. Initial capture of leukocytes is
dependent on P-selectin expression.13 Preliminary studies sug-
gest that elevated levels of vasoconstrictors such as vasopressin
or endothelin-1 (ET-1) contribute to leukocyte–endothelial cell
interactions via P-selectin surface expression but do not provoke
cellular migration.14,15 Ang II is the dominant vasoconstrictor in
many vascular diseases, and it might constitute a stimulus for the
subendothelial infiltration of leukocytes associated with these
pathological conditions. Therefore, in the present study, we
investigated the capacity and profile of Ang II and the molecular
mechanisms by which it elicits in vivo leukocyte–endothelial
cell interactions within the rat mesenteric microcirculation.
Methods
Intravital Microscopy
The details of the experimental preparation have been described
previously.15 In short, Sprague-Dawley rats (200 to 250 g) were
Received May 23, 2000; revision received May 31, 2000; accepted June 1, 2000.
From the Departments of Pharmacology (L.P., A.A., J.V.E., M.-J.S.) and Biochemistry (E.O.), University of Valencia, Spain; the Immunology
Research Group, University of Calgary, Canada (P.K.); and Departments of Pediatrics, Pathology, Microbiology, and Immunology, Dalhousie University,
Halifax, Canada (A.C.I.).
Reprint requests to Dr Maria-Jesus Sanz, Departamento de Farmacologı´a, Facultad de Medicina, Av. Blasco Iban˜ez, 15-17, 46010 Valencia, Spain.
E-mail maria.j.sanz@uv.es
© 2000 American Heart Association, Inc.
Circulation is available at http://www.circulationaha.org
2118
 at SWETS SUBS SERV-#54225388 on May 14, 2010 circ.ahajournals.orgDownloaded from 
fasted for 24 hours and anesthetized with pentobarbital sodium (50
mg/kg IP), and the trachea, right carotid artery, and jugular vein were
cannulated. After a midline abdominal incision, a segment of the
midjejunal mesentery was exteriorized and placed over an optically
clear viewing pedestal maintained at 37°C, which permitted tissue
transillumination. The exposed mesentery was superfused continu-
ously with a warmed bicarbonate-buffered saline (pH 7.4). An
orthostatic microscope (Nikon Optiphot-2, SMZ1) equipped with an
320 objective lens (Nikon SLDW) and an 310 eyepiece allowed
tissue visualization. A video camera (Sony SSC-C350P) mounted on
the microscope projected the image onto a color monitor (Sony
Trinitron PVM-14N2E), and the images were video recorded (Sony
SVT-S3000P) for playback analysis (final magnification of the video
screen was 31300). Single unbranched mesenteric venules were
selected, and the diameters (20 to 40 mm) were measured online with
a video caliper (Microcirculation Research Institute, Texas A&M
University). The number of rolling, adherent, and emigrated leuko-
cytes was determined offline during playback of videotaped images.
Centerline red blood cell velocity was also measured online with an
optical Doppler velocimeter (Microcirculation Research Institute,
Texas A&M University). Venular blood flow and wall shear rate
were calculated as previously described.15
Experimental Protocol
Preparations were allowed to stabilize for 30 minutes before baseline
(time 0) measurements of mean arterial blood pressure, red blood
cell velocity, vessel diameter, shear rate, leukocyte rolling flux and
velocity, and leukocyte adhesion and emigration were obtained. The
superfusion buffer was then supplemented with Ang II (0.1 to 100
nmol/L), and subsequent recordings were performed for 5 minutes at
15-minute intervals over a 60-minute period. On the basis of these
initial experiments, 1 nmol/L Ang II was used for the remainder of
the experiments.
Involvement of mast cell activation was determined by pretreat-
ment of a group of animals before the start of surgery with sodium
cromoglycate (cromolyn, 20 mg/kg IV), a mast cell–stabilizing
agent, 0.33 mg/mL of which was added to the superfusate containing
Ang II, as previously described.15
To identify which Ang II receptor was implicated, selective
antagonists of receptor subtype AT1 (losartan, 10 mg/kg IV), subtype
AT2 (PD123,319, 10 mg/kg IV), or a combination of the 2 were
administered 15 minutes before suffusion with Ang II 1 nmol/L. The
doses of both antagonists were based on previous in vivo data.16,17
The adhesion molecules involved in these responses were deter-
mined by pretreatment of the animals 5 minutes before Ang II
suffusion with fucoidin (25 mg/kg IV), a P- and L-selectin–binding
carbohydrate, an adhesion-blocking monoclonal antibody (mAb)
directed against rat P-selectin (RMP-1, IgG2a, 2.5 mg/kg IV), or the
nonblocking anti–rat P-selectin mAb (RP-2, IgG1, 2.5 mg/kg IV).15
Flow Cytometry
All the analyses were performed with an EPICS XL-MCL Flow
Cytometer (Coulter Electronics) as described previously.15
Determination of Surface Expression of CD11b/CD18
(aMb2) Integrins and L-Selectin (CD62L) in Rat PMNs
and Monocytes
Duplicated samples (100 mL) of rat citrated peripheral whole blood
were incubated for 15 minutes at 25°C with vehicle, PAF (1000
nmol/L), or Ang II (10 to 10 000 nmol/L). Samples were then
incubated in darkness and on ice for 20 minutes with saturating
amounts (10 mL) of the corresponding FITC-conjugated mAb.
Removal of red blood cells and fixation of leukocytes was performed
through an automated lysing procedure with an EPICS Q-PREP
system (Coulter Electronics).
Determination of Surface Expression of P-Selectin in
Rat Platelets
Rat citrated peripheral whole blood with prostaglandin E1 (PGE1)
(1 mmol/L) was diluted 1:10 in modified Tyrode’s buffer, and the
procedure followed was similar to that previously described.15
Statistical Analysis
All data are expressed as mean6SEM. The data within groups were
compared by a paired Student’s t test. An unpaired Student’s t test
was used to compare groups. In both cases, the Student’s t test was
performed with a Bonferroni correction for multiple comparisons. A
value of P,0.05 was considered statistically significant.
Materials
Ang II, Cromolyn, Thrombin, PGE1, Mouse IgG1, Goat Anti-
Mouse IgG1-FITC, and PD123,319 were purchased from Sigma
Chemical Co. Losartan was kindly donated by Merck Sharp &
Dohme. Antibodies RMP-1 and RP-2 were acquired as previously
stated.18 Conjugated mAb anti–rat-CD11b-FITC (OX-42) was pur-
chased from Immunotech. Anti–rat L-selectin (HRL-3) and anti–
hamster IgG FITC were supplied by LabClinics SA.
Results
The time- and concentration-dependent effects of Ang II on
leukocyte rolling flux and rolling velocity are shown in
Figure 1. Significant increases in leukocyte rolling and
significant concomitant decreases in the leukocyte rolling
velocity were observed at each stage for all concentrations
with optimal changes at 1 nmol/L of Ang II (83.8620.7
versus 16.463.1 cells/min and 37.363.5 versus
143.1642.9 mm/s at 60 minutes, respectively). Similarly,
Ang II induced a time- and concentration-dependent increase
in leukocyte adhesion and emigration at 30 and 60 minutes, as
shown in Figure 2 (11.461.0 versus 0.860.5 cells/100 mm
and 4.060.7 versus 0.260.2 cells/field at 60 minutes, respec-
tively, with the 1-nmol/L dose of Ang II).
Ang II 0.1 to 10 nmol/L induced no significant changes in
arteriolar or venular diameter or mean arterial blood pressure
(data not shown). However, 100 nmol/L Ang II, despite
causing similar leukocyte responses, provoked a significant
Figure 1. Dose-response and time-dependent effects of Ang II
superfusion on leukocyte rolling flux (A) and rolling velocity (B) in
rat mesenteric postcapillary venules. Animals were divided into
5 groups: buffer (n56) or Ang II 0.1 nmol/L, n54; 1 nmol/L,
n55; 10 nmol/L, n54; and 100 nmol/L, n55, and parameters
were measured at 0, 15, 30, and 60 minutes. Results are
mean6SEM. *P,0.05, **P,0.01 vs control value (0 minutes) for
animals within each group.
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vasoconstriction in both venular and arteriolar diameter, a
significant decrease in shear rate, and the collapse of 40% of
the vessels investigated. Therefore, a single dose of 1 nmol/L
Ang II, 100-fold less than a dose that caused vasoconstriction,
was selected to investigate further the mechanisms of Ang
II–induced leukocyte–endothelial cell interactions.
Flow cytometry analysis showed that whereas PAF in-
duced L-selectin shedding and increased expression of
CD11b/CD18 integrins in both leukocyte subtypes, Ang II at
10 to 10 000 nmol/L had no effect on expression of either of
these leukocyte surface adhesion molecules (Figure 3).
Stabilization of mast cells by cromolyn administration had
no influence on Ang II–elicited effects (Figure 4). In contrast,
as shown in Figure 5, both losartan and PD123,319 pretreat-
ment significantly reduced leukocyte rolling flux, adhesion,
and emigration after Ang II suffusion. However, neither
antagonist completely inhibited these responses. This was
obtained only after simultaneous administration of both
receptor antagonists. Furthermore, fucoidin pretreatment
abolished the leukocyte–endothelial cell interactions induced
by Ang II (Figure 6). Although pretreatment with the
P-selectin–blocking antibody RMP-1 inhibited the leukocyte
rolling, adhesion, and emigration associated with Ang II
superfusion, administration of a binding, nonblocking control
antibody (RP-2) had little or no effect on the Ang II–induced
responses (Figure 7). Finally, flow cytometry analysis on rat
platelets revealed the lack of effect of Ang II on platelet
P-selectin expression (Figure 8).
Discussion
Leukocyte accumulation in the vessel wall is a hallmark of
early stages of atherosclerosis, acute myocardial infarction,
and renal diseases of diverse causes in which Ang II seems to
play a critical role.2,10,19 In this study, we show that subva-
soconstrictor and physiologically relevant doses of Ang II
(0.1 to 1 nmol/L) induce a significant increase in leukocyte–
endothelial cell interactions. This observation suggests that in
various diseases, inappropriate leukocyte–endothelial cell
interactions occur before hypertension and in response to
elevated Ang II levels. Indeed, this is one of the most striking
observations of this study, because it indicates that disruption
of the vascular balance between vasodilators and vasocon-
strictors may expose the vascular endothelium to the delete-
rious action of the latter. Ang II therefore could trigger the
initial leukocyte recruitment that leads to the subsequent
vascular damage observed in hypertension, atherosclerosis,
and myocardial ischemia-reperfusion injury, constituting a
prominent role for this molecule in the pathogenesis of these
cardiovascular disease states.
Also significant is the fact that although Ang II elicits
leukocyte adhesion and emigration, flow cytometry analysis
revealed that it has no direct effect on leukocyte chemotaxis.
Several explanations may account for the proadhesive effects
observed. It is likely that Ang II activates the endothelium
and induces leukocyte rolling, which leads to firm adhesion
of leukocytes to the endothelium, resulting in their subse-
quent emigration. Indeed, we discovered that the initial
leukocyte–endothelial cell interactions induced by Ang II are
due to P-selectin expression on the endothelium. The firm
adhesion could also be due to the release of endogenously
generated chemotactic mediators elicited by Ang II. In this
context, there is some evidence that Ang II can evoke
leukocyte recruitment through increased expression and in-
Figure 2. Dose-response and time-dependent effects of Ang II
superfusion on leukocyte adhesion (A) and emigration (B) in rat
mesenteric postcapillary venules. Parameters were determined
at 0, 15, 30, and 60 minutes after superfusion with Ang II 0.1
nmol/L, n54; 1 nmol/L, n55; 10 nmol/L, n54; or 100 nmol/L,
n55 or without Ang II (n56). Results are mean6SEM. *P,0.05,
**P,0.01 vs control value (0 minutes) for animals within each
group.
Figure 3. Effect of stimulation with PAF 1000 nmol/L or Ang II
1000 nmol/L on surface expression of CD11b/CD18 integrin and
L-selectin on both rat neutrophils and monocytes. FITC fluores-
cence values are expressed as percentage of mean fluores-
cence intensities of control cells (dotted line). Data are
mean6SEM of 4 experiments. *P,0.05, **P,0.01 vs absolute
mean fluorescence intensity between control samples and
agonist-treated samples.
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duction of chemotactic mediators such as IL-8, MCP-1, or
RANTES.5,10,12 In fact, IL-8 was recently shown to be
costored with P-selectin in Weibel-Palade bodies.20 In addi-
tion, Mangat et al21 have showed a role for Ang II in cytosolic
phospholipase A2 activation, which is critical for the synthesis
and release of potent chemotactic mediators such as PAF or
leukotriene B4. This is relevant because the release of these
inflammatory mediators may constitute an amplifying mech-
anism for further leukocyte recruitment after Ang II
stimulation.
We have also demonstrated the role of both Ang II receptor
subtypes, AT1 and AT2, on Ang II–induced effects within the
rat mesenteric microcirculation, because a combination of
both receptor blockers returned all parameters to basal levels.
Notably, the present findings are supported by in vitro data,
albeit under static conditions, in which the involvement of
both receptor subtypes in the adhesion of human monocytes
to endothelial cells after incubation with Ang II has been
demonstrated.8 We have also discarded the possibility of a
direct activation of mast cells on the release of mediators by
Ang II and demonstrated a direct effect on the endothelium
via endothelial P-selectin upregulation.
There is some evidence to suggest that Ang II induces
adhesion molecule expression, but these findings are contro-
versial. Some authors have found no role for E-selectin,
vascular cell adhesion molecule-1 (VCAM-1), or intercellular
cell adhesion molecule-1 (ICAM-1) in Ang II–induced mono-
cyte adhesion to cultured endothelial cells.8 Others have
found that treatment with ACE inhibitors downregulates the
expression of VCAM-1 and ICAM-1 in animal models.6,22
Similarly, enalaprilat treatment in septic patients decreases
the plasma levels of soluble adhesion molecules such as
E-selectin or ICAM-1.23 Furthermore, in an in vitro study,
Gra¨fe et al9 found a clear effect for Ang II in inducing
E-selectin expression on coronary endothelial cells.
In this way, our data clearly demonstrate an implication of
P-selectin in Ang II–mediated responses. First, pretreatment
of animals with fucoidin totally inhibited the leukocyte
responses elicited by Ang II. Second, administration of a
blocking anti–rat P-selectin mAb (RMP-1) abolished all Ang
Figure 4. Effect of cromolyn treatment on Ang II–induced leuko-
cyte rolling flux (A), adhesion (B), and emigration (C) in rat mes-
enteric postcapillary venules. Parameters were measured 0, 15,
30, and 60 minutes after superfusion with Ang II 1 nmol/L in ani-
mals untreated (n55) or pretreated with cromolyn (n56). Results
are mean6SEM.
Figure 5. Effect of selective AT1 (losartan) and AT2 (PD123,319)
receptor antagonists on Ang II–induced rolling flux (A), adhesion
(B), and emigration (C) in rat mesenteric postcapillary venules.
Parameters were measured 0, 15, 30, and 60 minutes after
superfusion with Ang II 1 nmol/L in animals untreated (n55) or
pretreated with losartan (n56), PD123,319 (n55), or a combina-
tion of both antagonists (n56). Results are mean6SEM.
*P,0.05, **P,0.01 vs untreated group.
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II–induced leukocyte–endothelial cell interactions. Hence,
we believe that responses induced by exogenous Ang II in our
experiments are mediated through P-selectin upregulation on
the endothelial cell surface. This conclusion is supported by
the fact that no platelet-platelet or platelet–endothelial cell
interactions were detected in this in vivo system and that flow
cytometry analysis revealed no changes in rat platelet
P-selectin expression after Ang II stimulation.
An explanation for all these findings is that at early stages
of elevated plasma levels of Ang II, the leukocyte–endothe-
lial cell interactions elicited by this peptide are mediated
primarily through P-selectin upregulation. In chronic disor-
ders, however, inducible adhesion molecules such as
E-selectin are synthesized and may contribute to further
leukocyte recruitment. Indeed, increased circulating levels of
P-selectin and, to a lesser extent, E-selectin can be found in
essential, renovascular, and malignant hypertension and in
hypercholesterolemic patients.24,25 Furthermore, it was re-
cently shown that in a mouse model of atherosclerosis, there
is a clear involvement of both P- and E-selectins in the
development of the atherosclerotic lesion at both early and
advanced stages.26
To summarize, we have demonstrated for the first time in
vivo that Ang II elicits leukocyte–endothelial cell interac-
tions within the rat mesenteric microcirculation at subvaso-
constrictor doses. This effect is both AT1 and AT2 receptor–
mediated and totally dependent on endothelial P-selectin
expression. Thus, Ang II may play a critical role in the
leukocyte attachment to and emigration through the vascular
endothelium and could contribute to the vascular damage
present in pathological conditions in which plasma levels of
this peptide are elevated.
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Figure 6. Effect of fucoidin pretreatment on Ang II–induced leu-
kocyte rolling flux (A), adhesion (B), and emigration (C) in rat
mesenteric postcapillary venules. Parameters were determined
at 0, 15, 30, and 60 minutes after Ang II 1 nmol/L superfusion in
animals untreated (n55) or pretreated with fucoidin (n55).
Results are mean6SEM. *P,0.05, **P,0.01 vs untreated group.
Figure 7. Effect of anti–P-selectin treatment on Ang II–induced
leukocyte rolling flux (A), adhesion (B), and emigration (C) in rat
mesenteric postcapillary venules. Animals were divided into 3
groups: untreated (n55) and treated with a nonblocking (RP-2,
n55) or blocking (RMP-1, n57) anti–P-selectin mAb. Ang II 1
nmol/L superfusion was begun 5 minutes later, and parameters
were measured at 15, 30, and 60 minutes. Results are
mean6SEM. *P,0.05, **P,0.01 vs untreated group.
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